It could take more than 15 months to develop a vaccine for COVID -19

Since 2000, the Vaccine Alliance, GAVI has proved instrumental in responding to both long-term disease transmission as well as responding to rapid outbreaks. Gavi helped facilitate wider access to 300-thousand investigational doses of the recently approved Ebola vaccine. To reflect on the work of GAVI in response to the current COVID-19 pandemic that has brought the world to its knees, claiming tens of thousands of lives, Channel Africa's Zikhona Miso spoke to Managing Director of Country Programmes at Gavi, Thabani Maphosa